Literature DB >> 10639430

Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi.

C L Croke1, E L Munson, S D Lovrich, J A Christopherson, M C Remington, D M England, S M Callister, R F Schell.   

Abstract

Arthritis is a frequent and major complication of infection with Borrelia burgdorferi sensu stricto. The antigens responsible for the induction of arthritis are unknown. Here we provide direct evidence that a major surface protein, outer surface protein A (OspA), can induce arthritis. Hamsters were vaccinated with 30, 60, or 120 microg of recombinant OspA (rOspA) in aluminum hydroxide and challenged with B. burgdorferi sensu stricto isolate 297 or C-1-11. Swelling of the hind paws was detected in 100, 100, and 50% of hamsters vaccinated with 30, 60, or 120 microg of rOspA, respectively. In addition, arthritis developed in 57% of hamsters vaccinated with a canine rOspA vaccine after infection with B. burgdorferi sensu stricto. When the canine rOspA vaccine was combined with aluminum hydroxide, all vaccinated hamsters developed arthritis after challenge with B. burgdorferi sensu stricto. Histopathologic examination confirmed the development of severe destructive arthritis in rOspA-vaccinated hamsters challenged with B. burgdorferi sensu stricto. These findings suggest that rOspA vaccines should be modified to eliminate epitopes of OspA responsible for the induction of arthritis. Our results are important because an rOspA vaccine in aluminum hydroxide was approved by the Food and Drug Administration for use in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639430      PMCID: PMC97189          DOI: 10.1128/IAI.68.2.658-663.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi.

Authors:  S M Callister; K L Case; W A Agger; R F Schell; R C Johnson; J L Ellingson
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

2.  Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC.

Authors:  R D Gilmore; K J Kappel; M C Dolan; T R Burkot; B J Johnson
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

3.  Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters.

Authors:  L C Lim; D M England; N J Glowacki; B K DuChateau; R F Schell
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

4.  Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine.

Authors:  M L Padilla; S M Callister; R F Schell; G L Bryant; D A Jobe; S D Lovrich; B K DuChateau; J R Jensen
Journal:  J Infect Dis       Date:  1996-10       Impact factor: 5.226

5.  Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.

Authors:  M K Aydintug; Y Gu; M T Philipp
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

6.  Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.

Authors:  S D Lovrich; S M Callister; B K DuChateau; L C Lim; J Winfrey; S P Day; R F Schell
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

7.  T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice.

Authors:  A Keane-Myers; S P Nickell
Journal:  J Immunol       Date:  1995-02-15       Impact factor: 5.422

8.  Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice.

Authors:  A Keane-Myers; S P Nickell
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

9.  The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis.

Authors:  E Akin; G L McHugh; R A Flavell; E Fikrig; A C Steere
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

10.  T helper phenotype and genetic susceptibility in experimental Lyme disease.

Authors:  J E Matyniak; S L Reiner
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  16 in total

1.  Outer surface protein A and arthritis in hamsters.

Authors:  D L Parenti
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 2.  Lyme arthritis: current concepts and a change in paradigm.

Authors:  Dean T Nardelli; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

3.  Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4.

Authors:  E L Munson; B K Du Chateau; D A Jobe; S D Lovrich; S M Callister; R F Schell
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production.

Authors:  Dean T Nardelli; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2006-08

5.  Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice.

Authors:  Joseph Kuo; Dean T Nardelli; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

6.  Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro.

Authors:  Erik L Munson; Brian K Du Chateau; Jani R Jensen; Steven M Callister; David J DeCoster; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

7.  Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species.

Authors:  Nicholas J Kotloski; Dean T Nardelli; Sara Heil Peterson; Jose R Torrealba; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

8.  Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi.

Authors:  Matthew A Burchill; Dean T Nardelli; Douglas M England; David J DeCoster; John A Christopherson; Steven M Callister; Ronald F Schell
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice.

Authors:  Erik L Munson; David J DeCoster; Dean T Nardelli; Douglas M England; Steven M Callister; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

10.  Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.

Authors:  Sara Heil Peterson; Dean T Nardelli; Thomas F Warner; Steven M Callister; Jose R Torrealba; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.